Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1058)
|
Core Tip (1069)
|
Full Article (HTML) (3679)
|
Full Article (PDF)-777K (600)
|
Audio-357K (35)
|
Peer-Review Report-122K (152)
|
Answering Reviewers-64K (192)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (10517)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1201)
|
Core Tip (1225)
|
Full Article (HTML) (10596)
|
Figures (1-4) (1260)
|
Full Article (PDF)-948K (1280)
|
Audio-1310K (28)
|
Peer-Review Report-106K (367)
|
Answering Reviewers-19K (229)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (55)
|
Total Visits (22807)
|
Similar Articles (477)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1136)
|
Core Tip (1125)
|
Full Article (HTML) (4544)
|
Figures (1-2) (232)
|
Tables (1-2) (219)
|
Full Article (PDF)-1246K (689)
|
Audio-442K (32)
|
Peer-Review Report-131K (305)
|
Answering Reviewers-120K (192)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (15942)
|
Similar Articles (15)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1042)
|
Core Tip (1052)
|
Full Article (HTML) (3443)
|
Figures (1-3) (235)
|
Tables (1-1) (226)
|
Full Article (PDF)-814K (500)
|
Audio-757K (21)
|
Peer-Review Report-105K (231)
|
Answering Reviewers-109K (207)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (14529)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1099)
|
Core Tip (1113)
|
Full Article (HTML) (3645)
|
Tables (1-3) (210)
|
Full Article (PDF)-799K (466)
|
Audio-1969K (21)
|
Peer-Review Report-132K (211)
|
Answering Reviewers-50K (185)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (13027)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open